369 related articles for article (PubMed ID: 33251778)
1. Combination Therapy by Tissue-Specific Suicide Gene and Bevacizumab in Intramedullary Spinal Cord Tumor.
Gwak SJ; Che L; Yun Y; Lee M; Ha Y
Yonsei Med J; 2020 Dec; 61(12):1042-1049. PubMed ID: 33251778
[TBL] [Abstract][Full Text] [Related]
2. Delivery of hypoxia and glioma dual-specific suicide gene using dexamethasone conjugated polyethylenimine for glioblastoma-specific gene therapy.
Kim HA; Park JH; Yi N; Lee M
Mol Pharm; 2014 Mar; 11(3):938-50. PubMed ID: 24467192
[TBL] [Abstract][Full Text] [Related]
3. Reducible Poly(Oligo-D-Arginine) as an Efficient Carrier of the Thymidine Kinase Gene in the Intracranial Glioblastoma Animal Model.
Kim HA; Lee HL; Choi E; Kim YH; Lee M
J Pharm Sci; 2015 Nov; 104(11):3743-3751. PubMed ID: 26178805
[TBL] [Abstract][Full Text] [Related]
4. Peptide micelle-mediated delivery of tissue-specific suicide gene and combined therapy with avastin in a glioblastoma model.
Oh B; Han J; Choi E; Tan X; Lee M
J Pharm Sci; 2015 Apr; 104(4):1461-9. PubMed ID: 25631673
[TBL] [Abstract][Full Text] [Related]
5. Effect of combined bevacizumab and temozolomide treatment on intramedullary spinal cord tumor.
Gwak SJ; An SS; Yang MS; Joe E; Kim DH; Yoon DH; Kim KN; Ha Y
Spine (Phila Pa 1976); 2014 Jan; 39(2):E65-73. PubMed ID: 24158177
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible expression of vascular endothelial growth factor for the treatment of spinal cord injury in a rat model.
Choi UH; Ha Y; Huang X; Park SR; Chung J; Hyun DK; Park H; Park HC; Kim SW; Lee M
J Neurosurg Spine; 2007 Jul; 7(1):54-60. PubMed ID: 17633488
[TBL] [Abstract][Full Text] [Related]
7. Targeted Treatment of Experimental Spinal Cord Glioma With Dual Gene-Engineered Human Neural Stem Cells.
Ropper AE; Zeng X; Haragopal H; Anderson JE; Aljuboori Z; Han I; Abd-El-Barr M; Lee HJ; Sidman RL; Snyder EY; Viapiano MS; Kim SU; Chi JH; Teng YD
Neurosurgery; 2016 Sep; 79(3):481-91. PubMed ID: 26671631
[TBL] [Abstract][Full Text] [Related]
8. A novel model of intramedullary spinal cord tumors in rats: functional progression and histopathological characterization.
Caplan J; Pradilla G; Hdeib A; Tyler BM; Legnani FG; Bagley CA; Brem H; Jallo G
Neurosurgery; 2006 Jul; 59(1):193-200; discussion 193-200. PubMed ID: 16823316
[TBL] [Abstract][Full Text] [Related]
9. Animal model of intramedullary spinal cord glioma using human glioblastoma multiforme neurospheres.
Hsu W; Siu IM; Pradilla G; Gokaslan ZL; Jallo GI; Gallia GL
J Neurosurg Spine; 2012 Mar; 16(3):315-9. PubMed ID: 22195609
[TBL] [Abstract][Full Text] [Related]
10. Molecular ablation of tumor blood vessels inhibits therapeutic effects of radiation and bevacizumab.
Yadav VN; Altshuler D; Kadiyala P; Zamler D; Comba A; Appelman H; Dunn P; Koschmann C; Castro MG; Löwenstein PR
Neuro Oncol; 2018 Sep; 20(10):1356-1367. PubMed ID: 29660022
[TBL] [Abstract][Full Text] [Related]
11. Suicide gene therapy using reducible poly (oligo-D-arginine) for the treatment of spinal cord tumors.
Won YW; Kim KM; An SS; Lee M; Ha Y; Kim YH
Biomaterials; 2011 Dec; 32(36):9766-75. PubMed ID: 21924768
[TBL] [Abstract][Full Text] [Related]
12. Lentiviral-Induced Spinal Cord Gliomas in Rat Model.
Nagarajan PP; Tora MS; Neill SG; Federici T; Texakalidis P; Donsante A; Canoll P; Lei K; Boulis NM
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884748
[TBL] [Abstract][Full Text] [Related]
13. A reproducible model of intramedullary spinal cord tumor in rats bearing RG2 cells.
Zhuang Y; Zhao W; Zhang W; Wei H; Huang X; Cai G; Fu C; Wang C; Wang R; Shi S; Yang W; Chen C
Oncotarget; 2017 May; 8(19):30971-30977. PubMed ID: 28415681
[TBL] [Abstract][Full Text] [Related]
14. Delivery of Hypoxia-Inducible Heme Oxygenase-1 Gene for Site-Specific Gene Therapy in the Ischemic Stroke Animal Model.
Choi M; Oh J; Rhim T; Lee M
Pharm Res; 2016 Sep; 33(9):2250-8. PubMed ID: 27324961
[TBL] [Abstract][Full Text] [Related]
15. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma.
Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH
Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433
[TBL] [Abstract][Full Text] [Related]
16. Ischemic injury-specific gene expression in the rat spinal cord injury model using hypoxia-inducible system.
Lee M; Lee ES; Kim YS; Choi BH; Park SR; Park HS; Park HC; Kim SW; Ha Y
Spine (Phila Pa 1976); 2005 Dec; 30(24):2729-34. PubMed ID: 16371895
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy with an erythropoietin enhancer-mediated, hypoxia-inducible gene expression system in the corpus cavernosum of mice with high-cholesterol diet-induced erectile dysfunction.
Ryu JK; Lee M; Choi MJ; Kim HA; Jin HR; Kim WJ; Yin GN; Song KM; Kwon MH; Suh JK
J Androl; 2012; 33(5):845-53. PubMed ID: 22403284
[TBL] [Abstract][Full Text] [Related]
18. Characterization of neural stem cells modified with hypoxia/neuron-specific VEGF expression system for spinal cord injury.
Yun Y; Oh J; Kim Y; Kim G; Lee M; Ha Y
Gene Ther; 2018 Jan; 25(1):27-38. PubMed ID: 29155421
[TBL] [Abstract][Full Text] [Related]
19. A hypoxia-inducible gene expression system using erythropoietin 3' untranslated region for the gene therapy of rat spinal cord injury.
Choi BH; Ha Y; Ahn CH; Huang X; Kim JM; Park SR; Park H; Park HC; Kim SW; Lee M
Neurosci Lett; 2007 Jan; 412(2):118-22. PubMed ID: 17178192
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible gene expression system using the erythropoietin enhancer and 3'-untranslated region for the VEGF gene therapy.
Lee M; Choi D; Choi MJ; Jeong JH; Kim WJ; Oh S; Kim YH; Bull DA; Kim SW
J Control Release; 2006 Sep; 115(1):113-9. PubMed ID: 16962197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]